Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2,060.00
  • Today's Change0.00 / 0.00%
  • Shares traded61.19k
  • 1 Year change2.08%
  • Beta0.3294
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue669690593
OPERATING EXPENSES
Cost of revenue total------
Selling, general and admin. expenses, total7.006.003.70
Depreciation/amortization5.807.708.30
Unusual expense(income)48207.40
Other operating expenses, total602615525
Total operating expense662649544
Operating income6.404149
Other, net(0.7)1.90(0.5)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes5.503948
Provision for income taxes3.107.6012
Net income after taxes2.403237
Minority interest5.501.504.20
Net income before extra. Items7.903341
Total extraordinary items------
Net income7.903341
Inc.avail. to common excl. extra. Items7.903341
Inc.avail. to common incl. extra. Items7.903341
EPS RECONCILIATION
Basic/primary weighted average shares666665
Basic/primary eps excl. extra items0.120.510.63
Basic/primary eps incl. extra items0.120.510.63
Dilution adjustment------
Diluted weighted average shares666665
Diluted eps excl. extra items0.120.500.63
Diluted eps incl. extra items0.120.500.63
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.320.320.32
Gross dividend - common stock--21--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental22156.10
SUPPLEMENTAL INCOME
Depreciation, supplemental353026
Total special items50207.40
NORMALISED INCOME
Normalized income before taxes556056
Effect of special items on income taxes283.941.79
Income tax excluding impact of special items311213
Normalized income after tax244842
Normalized income avail. to common305047
Basic normalized EPS0.450.760.71
Diluted normalized EPS0.450.750.71
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.